ArchiMed
PE · New York · United States
Stages
Investment region
Industries
Profile
ArchiMed is a healthcare-focused private equity investor based in Europe, established by healthcare professionals. The firm consists of over 160 professionals, including finance experts, scientists, and operational managers. They distinguish themselves by accelerating the development of healthcare industries and solutions that benefit people and patients around the world. ArchiMed is known for its team’s ability to leverage their scientific and operational expertise to foster growth in their portfolio companies. ArchiMed invests exclusively in the healthcare sector, covering sub-sectors such as pharmaceuticals, medical devices, and healthcare services. The firm generally targets leveraged buyouts with check sizes typically in the $50-100 million range. The structured stages include acquisitions, and series B investments within North America and Europe. They manage several funds, including the MED Platform I and MED Platform II funds, summing up to significant assets under management. Notable investments include Esperion Therapeutics - biopharmaceuticals, Cardioline - cardiovascular monitoring, Corealis - pharmaceutical solutions, and IRAB - science and technology development. Their strategic acquisitions and impactful healthcare investments emphasize their prowess in the sector.
Contacts (2)
| Name | Title | Phone | ||
|---|---|---|---|---|
| Chairman, Managing Partner | — | — | — | |
| Managing Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.